Photo: investing.com
BrainsWay Expands U.S. Reach with Two New Investments in Mental Health Providers
BrainsWay Ltd. expands its presence in the U.S. mental health market by investing in two additional providers, enhancing its neurostimulation offerings and supporting transcranial magnetic stimulation treatments.
- In 2025, BrainsWay Ltd. secured minority stakes in two U.S. mental health providers, increasing its total investments in this sector to four.
- The company signed an equity financing agreement with Tangient ATX Inc., which operates within the Heading Health clinic network across Texas, focusing on mental health solutions.
- BrainsWay reported a robust revenue growth of 26.5% over the last twelve months, reflecting the increasing demand for innovative neurostimulation therapies like transcranial magnetic stimulation.
Por Qué Es Relevante
This expansion signifies BrainsWays commitment to enhancing mental health treatment options in the U.S., aligning with the growing recognition of the importance of effective neurostimulation therapies in addressing mental health challenges.